Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31074 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Orlane Magnier und 25 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Blood Diseases Department, Medical Oncology, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Neuroblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Association Grenobloise de Développement d'Etudes et Recherches en Médecine Infantile (AGDERMI).
Abstract (Originalsprache)
Background
Adult‐ and adolescent‐onset neuroblastomas are rare, with no established therapy. In addition, rare pheochromocytomas may harbor neuroblastic components. This study was designed to collect epidemiological, diagnostic and therapeutic data in order to better define the characteristics of malignant peripheral neuroblastic tumors (MPNT) and composite pheochromocytomas (CP) with MPNT. Procedure Fifty‐nine adults and adolescents (aged over 15 years) diagnosed with a peripheral or composite neuroblastic tumor, who were treated in one of 17 institutions between 2000 and 2020, were retrospectively studied.
Results
Eighteen patients with neuroblastoma (NB) or ganglioneuroblastoma (GNB) had locoregional disease, and 28 patients had metastatic stage 4 NB. Among the 13 patients with CP, 12 had locoregional disease. Fifty‐eight percent of the population were adolescents and young adults under 24 years of age. The probability of 5‐year event‐free survival (EFS) was 40% (confidence interval: 27%–53%).
Conclusions
Outcomes were better for patients with localized tumor than for patients with metastases. For patients with localized tumor, in terms of survival, surgical treatment was the best therapeutic option. Multimodal treatment with chemotherapy, surgery, radiotherapy, and immunotherapy‐based maintenance allowed long‐term survival for some patients. Adolescent‐ and adult‐onset neuroblastoma appeared to have specific characteristics associated with poorer outcomes compared to pediatric neuroblastoma. Nevertheless, complete disease control improved survival. The presence of a neuroblastic component in pheochromocytoma should be considered when making therapeutic management decisions. The development of specific tools/resources (Tumor Referral Board, Registry, biology, and trials with new agents or strategies) may help to improve outcomes for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer and Blood Diseases Department, Medical Oncology, Grenoble Alpes University Hospital, Grenoble, France.
- Pediatric Oncology and Hematology Department, Grenoble Alpes University, Grenoble, France.
- Endocrinology Department, Grenoble Alpes University, Grenoble, France.
- Public Health and Biostatistics, Grenoble Alpes University Hospital, Grenoble, France.
- Pediatric and AYA Oncology Department, Oscar Lambret Center, Lille, France.
- Pediatric Oncology Department, Curie Institute, Paris, France.
ORCID-Profile: Orlane Magnier, Anne-Sophie Defachelles, Pablo Berlanga
Förderung
- Association Grenobloise de Développement d'Etudes et Recherches en Médecine Infantile (AGDERMI)
Zitieren
APA
Magnier, O., Schiff, I., Cristante, J., Chabre, O., Veloso, M., Bosson, J. L., Defachelles, A. S., Cordero, C., Do Cao, C., Thebaud, E., Drui, D., Berlanga, P., Dumont, B., Chastagner, P., Tandonnet, J., Gambart, M., Jannier, S., Pluchart, C., Andry, L., …, & Plantaz, D. (2024). Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31074
Vancouver
Magnier O, Schiff I, Cristante J, Chabre O, Veloso M, Bosson JL, et al. Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31074
BibTeX
@article{Magnier2024,
author = {Magnier, Orlane and Schiff, Isabelle and Cristante, Justine and Chabre, Olivier and Veloso, Melanie and Bosson, Jean-Luc and Defachelles, Anne-Sophie and Cordero, Camille and Do Cao, Christine and Thebaud, Estelle and Drui, Delphine and Berlanga, Pablo and Dumont, Benoit and Chastagner, Philippe and Tandonnet, Julie and Gambart, Marion and Jannier, Sarah and Pluchart, Claire and Andry, Leslie and Laithier, Véronique and Klein, Sébastien and Carausu, Liana and Akbaraly, Tasmine and Probert, Jamie and Habert-Dantigny, Raphaelle and Plantaz, Dominique},
title = {Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31074}
}
EUVIMED